These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8001187)

  • 21. [Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].
    Bedenne L; Seitz JF; Milan C; Renard P; Fraisse J; Conroy T; Lacourt J; Janoray P; Faivre J
    Gastroenterol Clin Biol; 1998 Mar; 22(3):273-81. PubMed ID: 9762210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neoadjuvant treatment in surgery of esophageal cancer].
    Launois B; Raoul JL; Leprise E; Meunier B
    Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
    Taieb S; Vaillant E; Pommier P; Bonvoisin S; Desseigne F; Morignat E; Gerard JP; Mornex F
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1048-54. PubMed ID: 10592877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy].
    Ando N; Ozawa S; Kitagawa Y; Takeuchi H; Kitajima M
    Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):767-72. PubMed ID: 9370137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative evaluation of radiotherapy and chemoradiotherapy in inoperable cancer of the esophagus].
    Aliev BM; Khydyrov KhB; Kondrat'eva NF
    Med Radiol (Mosk); 1990 Apr; 35(4):24-7. PubMed ID: 1692388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidermoid cancers of the esophagus: combined chemotherapy, surgery and radiotherapy. Preliminary results in 50 cases].
    Elias D; Lasser P; Kac J; Spielmann M; Eschwege F; Girinsky T; Bertin F; Leclercq B; Nitenberg G; Rougier P
    Bull Cancer; 1988; 75(2):175-81. PubMed ID: 3359061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative chemotherapy followed by esophagectomy compared with surgery alone in the treatment of squamous cell carcinoma of the esophagus.
    Hernández Lizoain JL; Cienfuegos JA; Pardo F; Martínez Regueira F; Sola I; Aristu J; Azinovic I
    Rev Esp Enferm Dig; 1998 Apr; 90(4):275-90. PubMed ID: 9623271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.
    Adelstein DJ; Rice TW; Becker M; Larto MA; Kirby TJ; Koka A; Tefft M; Zuccaro G
    Cancer; 1997 Sep; 80(6):1011-20. PubMed ID: 9305700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of cisplatin in concurrent use with radiotherapy in esophageal carcinoma--joint research among nationwide multi-facilities, primary results. Research Committee for Radiation and Cisplatin Treatment of Esophageal Carcinoma].
    Ishikawa T; Irie G; Asakawa H; Ikeda M; Dokiya T; Morita K; Inoue T; Masuda K
    Gan No Rinsho; 1990 Jan; 36(1):1-6. PubMed ID: 2405207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer.
    Farkas R; Pozsgai E; Bellyei S; Cseke L; Szigeti A; Vereczkei A; Marton S; Mangel L; Horvath OP; Papp A
    Anticancer Res; 2011 May; 31(5):1769-75. PubMed ID: 21617238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma.
    Saeki H; Morita M; Nakashima Y; Sonoda H; Hashimoto K; Egashira A; Oki E; Ohga T; Kakeji Y; Maehara Y
    Anticancer Res; 2011 Sep; 31(9):3073-7. PubMed ID: 21868562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.